Indonesia has launched human trials of a Chinese-made coronavirus vaccine with some 1,600 volunteers slated to take part in the six-month study, according to AFP.
The vaccine candidate, produced by Sinovac Biotech, is among just a few in the world to enter Phase 3 clinical trials, or large-scale testing on humans — the last step before regulatory approval.
The treatment, known as CoronaVac, is already being tested on 9,000 health workers in Brazil, the second hardest-hit country in the coronavirus pandemic after the United States.
The governor of Indonesia's most populous province, West Java, was among 1,620 volunteers slated to take part in clinical testing, which was set to wrap up in February.
